Evidence map›Paper›PMID 23640885›Full record

ArticleThe Journal of biological chemistry2013

The fibroblast growth factor 14·voltage-gated sodium channel complex is a new target of glycogen synthase kinase 3 (GSK3).

Alexander S Shavkunov, Norelle C Wildburger, Miroslav N Nenov, Thomas F James, Tetyana P Buzhdygan, Neli I Panova-Elektronova, Thomas A Green, Ronald L Veselenak, Nigel Bourne, Fernanda Laezza

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 88 citations in OpenAlex.

  1. In Vivo Expression of an SCA27A-LinkedThe Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  2. Article
  3. Inhibition of the GSK3β/Nav1.6 complex suppresses early-stage Alzheimer's hyperexcitability.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Voltage-Gated NaLife (Basel, Switzerland) · 2023
    Review
  10. Article
  11. Glycogen Synthase Kinase 3: Ion Channels, Plasticity, and Diseases.International journal of molecular sciences · 2022
    Review
  12. Inhibition of the Akt/PKB Kinase Increases NaInternational journal of molecular sciences · 2022
    Article
  13. Article
  14. Convergent genomic and pharmacological evidence of PI3K/GSK3 signaling alterations in neurons from schizophrenia patients.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
    Article
  15. Article
  16. Differential Modulation of the Voltage-Gated NaFrontiers in molecular biosciences · 2021
    Article
  17. Article
  18. JAK2 regulates Nav1.6 channel function via FGF14Biochimica et biophysica acta. Molecular cell research · 2020
    Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Alexander S ShavkunovDepartment of Pharmacology and Toxicology, University of Texas Medical Branch, Galveston, Texas 77555, USA.
Norelle C Wildburger
Miroslav N Nenov
Thomas F James
Tetyana P Buzhdygan
Neli I Panova-Elektronova
Thomas A Green
Ronald L Veselenak
Nigel Bourne
Fernanda Laezza
The University of Texas Medical Branch at Galveston · USJohn Sealy Hospital · US

Funding

UTMB Clinical and Translational Science AwardUL1TR000071 · NCATS · UNIVERSITY OF TEXAS MED BR GALVESTON · PI BRASIER, ALLAN R. · 2012 to 2014
$14.4M
Validation of FGF14 as a New Molecular Target of GSK3R01MH095995 · NIMH · UNIVERSITY OF TEXAS MED BR GALVESTON · PI LAEZZA, FERNANDA · 2012 to 2016
$1.9M
NCATS NIH HHS UL1 TR000071NCATS NIH HHS UL1TR000071NIMH NIH HHS R01 MH095995NIMH NIH HHS S MH095995PHS HHS 5UC7A107008304
6 · The paper itself

Abstract

The FGF14 protein controls biophysical properties and subcellular distribution of neuronal voltage-gated Na(+) (Nav) channels through direct binding to the channel C terminus. To gain insights into the dynamic regulation of this protein/protein interaction complex, we employed the split luciferase complementation assay to screen a small molecule library of kinase inhibitors against the FGF14·Nav1.6 channel complex and identified inhibitors of GSK3 as hits. Through a combination of a luminescence-based counter-screening, co-immunoprecipitation, patch clamp electrophysiology, and quantitative confocal immunofluorescence, we demonstrate that inhibition of GSK3 reduces the assembly of the FGF14·Nav channel complex, modifies FGF14-dependent regulation of Na(+) currents, and induces dissociation and subcellular redistribution of the native FGF14·Nav channel complex in hippocampal neurons. These results further emphasize the role of FGF14 as a critical component of the Nav channel macromolecular complex, providing evidence for a novel GSK3-dependent signaling pathway that might control excitability through specific protein/protein interactions.

Indexed as

AnimalsEnzyme InhibitorsFibroblast Growth FactorsGlycogen Synthase Kinase 3HEK293 CellsHippocampusHumansMiceMice, KnockoutMultiprotein ComplexesNAV1.6 Voltage-Gated Sodium ChannelNeuronsRatsSignal TransductionEnzyme Inhibitorsfibroblast growth factor 14Fibroblast Growth FactorsGlycogen Synthase Kinase 3Multiprotein ComplexesNAV1.6 Voltage-Gated Sodium ChannelSCN8A protein, humanScn8a protein, mouseScn8a protein, ratExcitabilityFGF14GSK3Ion ChannelsNeuronsPhosphorylationProtein/Protein InteractionsSodium Channels

Identifiers

PMID23640885
PMCPMC3707642
OpenAlexW2088645977

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.